TP53 and gastric cancer: The results highlighted several frequently mutated genes in gastric cancer, including TP53 (58%), erb-b2 receptor tyrosine kinase 2 (ERBB2; HER2) (28%), and BRCA2 (23%), confirming their known roles in gastric tumorigenesis.